Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian M Jubb

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|December 6, 2025
Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)Mark S Shahin, Raina Mathur, Anju Parthan, et al.
Cancer Research|November 4, 2005
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancersDaniel Gray, Adrian M Jubb, Deborah Hogue, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2014
A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine modelsDara Y Kallop, William J Meilandt, Alvin Gogineni, et al.
Journal of the National Cancer Institute|July 7, 2005
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumabWilliam L Ince, Adrian M Jubb, Scott N Holden, et al.
Gut|May 29, 2012
In situ validation of an intestinal stem cell signature in colorectal cancerJennifer L Ziskin, Debra Dunlap, Murat Yaylaoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2005
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancerAdrian M Jubb, Herbert I Hurwitz, Wei Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancerAdrian M Jubb, Kathy D Miller, Hope S Rugo, et al.
Blood|November 9, 2012
LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenanceSung-Uk Lee, Manami Maeda, Yuichi Ishikawa, et al.
The American Journal of Pathology|February 20, 2010
Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancerAdrian M Jubb, Elizabeth J Soilleux, Helen Turley, et al.
Inflammatory Bowel Diseases|February 5, 2014
DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acidTammie S MacFie, Richard Poulsom, Alexandra Parker, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|December 6, 2025
Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)Mark S Shahin, Raina Mathur, Anju Parthan, et al.
Cancer Research|November 4, 2005
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancersDaniel Gray, Adrian M Jubb, Deborah Hogue, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2014
A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine modelsDara Y Kallop, William J Meilandt, Alvin Gogineni, et al.
Journal of the National Cancer Institute|July 7, 2005
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumabWilliam L Ince, Adrian M Jubb, Scott N Holden, et al.
Gut|May 29, 2012
In situ validation of an intestinal stem cell signature in colorectal cancerJennifer L Ziskin, Debra Dunlap, Murat Yaylaoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2005
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancerAdrian M Jubb, Herbert I Hurwitz, Wei Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancerAdrian M Jubb, Kathy D Miller, Hope S Rugo, et al.
Blood|November 9, 2012
LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenanceSung-Uk Lee, Manami Maeda, Yuichi Ishikawa, et al.
The American Journal of Pathology|February 20, 2010
Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancerAdrian M Jubb, Elizabeth J Soilleux, Helen Turley, et al.
Inflammatory Bowel Diseases|February 5, 2014
DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acidTammie S MacFie, Richard Poulsom, Alexandra Parker, et al.
Pageof 5